Finance

Lists
003000:KRX
Bukwang Pharm Co Ltd
3 890,00 KRW
-0,64%
(-25,00) 1D
21 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003000...
Open
3 940 KRW
High
4 020 KRW
Low
3 880 KRW
Mkt. cap
383,81 მლრ.
Avg. vol.
388,74 ათ.
Volume
170,93 ათ.
Dividend
3,21%
Quarterly dividend
31 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
42,11
52-wk high
9 890 KRW
52-wk low
3 510 KRW
EPS
92 KRW
Shares outstanding
98,66 მლნ.
No. of employees
630
Open
3 940 KRW
High
4 020 KRW
Low
3 880 KRW
Mkt. cap
383,81 მლრ.
Avg. vol.
388,74 ათ.
Volume
170,93 ათ.
Dividend
3,21%
Quarterly dividend
31 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
42,11
52-wk high
9 890 KRW
52-wk low
3 510 KRW
EPS
92 KRW
Shares outstanding
98,66 მლნ.
No. of employees
630
News stories
From web sources and news partners
About Bukwang Pharm Co Ltd
CEOკიმ სანგ-ჰუნ | ჰვი ვონ იუ
Employees630
Founded1960
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
47,81 მლრდ.
62,51 მლრდ.
47,78 მლრდ.
56,99 მლრდ.
Cost of goods sold
28,36 მლრდ.
29,86 მლრდ.
28,91 მლრდ.
32,59 მლრდ.
Cost of revenue
28,36 მლრდ.
29,86 მლრდ.
28,91 მლრდ.
32,59 მლრდ.
Research and development expenses
4,24 მლრდ.
6,31 მლრდ.
4,56 მლრდ.
7,08 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,23 მლრდ.
17,02 მლრდ.
11,50 მლრდ.
15,91 მლრდ.
Operating expense
18,47 მლრდ.
24,50 მლრდ.
17,76 მლრდ.
22,99 მლრდ.
Total operating expenses
46,84 მლრდ.
54,36 მლრდ.
46,67 მლრდ.
55,58 მლრდ.
Operating income
979,05 მლნ.
8,16 მლრდ.
1,10 მლრდ.
1,41 მლრდ.
Other non operating income
244,96 მლნ.
3,01 მლრდ.
981,71 მლნ.
449,24 მლნ.
EBT including unusual items
1,22 მლრდ.
2,99 მლრდ.
2,09 მლრდ.
1,84 მლრდ.
EBT excluding unusual items
1,22 მლრდ.
11,56 მლრდ.
2,09 მლრდ.
1,84 მლრდ.
Income tax expense
-272,07 მლნ.
-1,67 მლრდ.
924,48 მლნ.
447,55 მლნ.
Effective tax rate
-22,24%
-55,87%
44,32%
24,37%
Other operating expenses
-
628,87 მლნ.
546,78 მლნ.
-
Net income
1,53 მლრდ.
4,67 მლრდ.
1,18 მლრდ.
1,40 მლრდ.
Net profit margin
3,20%
7,47%
2,46%
2,46%
Earnings per share
-
-
-
-
Interest and investment income
-
4,71 მლრდ.
-
-
Interest expense
-
-3,90 მლრდ.
-
-
Net interest expenses
-
815,55 მლნ.
-
-
Depreciation and amortization charges
-
350,64 მლნ.
642,06 მლნ.
-
EBITDA
2,40 მლრდ.
9,70 მლრდ.
2,48 მლრდ.
2,48 მლრდ.
Gain or loss from assets sale
-299,00 ათ.
-12,46 მლნ.
-
-49,19 მლნ.
AI content may include mistakes. Learn more
Google აპები